Quest Diagnostics Incorporated (DGX) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Medical - Diagnostics & Research industria. La empresa tiene su sede en Secaucus, NJ, United States. El CEO actual es James E. Davis.
DGX tiene fecha de IPO 1996-12-17, 55,000 empleados a tiempo completo, cotiza en el NYSE, una capitalización de mercado de $21.49B.
Quest Diagnostics Incorporated is a leading provider of diagnostic testing, information, and services operating in the United States and internationally. The company delivers a comprehensive range of clinical laboratory services, including routine testing, advanced clinical testing, and anatomic pathology testing, serving patients, clinicians, hospitals, health plans, and employers through an extensive network of laboratories and patient service centers. Quest Diagnostics operates multiple diagnostic brands including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum, while also offering risk assessment services for the life insurance industry and healthcare information technology solutions to support clinical operations. Founded in 1967 and headquartered in Secaucus, New Jersey, the company leverages a diverse workforce of phlebotomists, nurses, and health professionals to deliver diagnostic information across multiple service channels.
